Failure of neuronal homeostasis results in common neuropsychiatric phenotypes (original) (raw)

• Verkerk, A. J. et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905–914 (1991).
  Article CAS Google Scholar
• Garber, K., Smith, K. T., Reines, D. & Warren, S. T. Transcription, translation and fragile X syndrome. Curr. Opin. Genet. Dev. 16, 270–275 (2006).
  Article CAS Google Scholar
• Comery, T. A. et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl Acad. Sci. USA 94, 5401–5404 (1997).
  Article CAS ADS Google Scholar
• Peier, A. M. et al. (Over) correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum. Mol. Genet. 9, 1145–1159 (2000).
  Article CAS Google Scholar
• Brown, V. et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477–487 (2001).
  Article CAS Google Scholar
• Darnell, J. C. et al. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107, 489–499 (2001).
  Article CAS Google Scholar
• Bear, M. F., Huber, K. M. & Warren, S. T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 27, 370–377 (2004).
  Article CAS Google Scholar
• Dolen, G. et al. Correction of fragile X syndrome in mice. Neuron 56, 955–962 (2007). This paper provides genetic evidence that supports the mGluR theory of fragile X pathogenesis and proposes a potential therapeutic strategy.
  Article CAS Google Scholar
• Nakamoto, M. et al. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc. Natl Acad. Sci. USA 104, 15537–15542 (2007).
  Article CAS ADS Google Scholar
• Muddashetty, R. S., Kelic, S., Gross, C., Xu, M. & Bassell, G. J. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J. Neurosci. 27, 5338–5348 (2007). This paper provides a mechanism underlying abnormal AMPA-receptor surface expression in excitatory synapses in fragile X syndrome and suggests that the key principle responsible for fragile X syndrome is that synaptic activation cannot stimulate the additional local protein synthesis necessary for synaptic plasticity to occur.
  Article CAS Google Scholar
• Yan, Q. J., Rammal, M., Tranfaglia, M. & Bauchwitz, R. P. Suppression of two major fragile X syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49, 1053–1066 (2005).
  Article CAS Google Scholar
• McBride, S. M. et al. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45, 753–764 (2005).
  Article CAS Google Scholar
• Kobrynski, L. J. & Sullivan, K. E. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370, 1443–1452 (2007).
  Article CAS Google Scholar
• Gothelf, D. et al. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am. J. Psychiatry 164, 663–669 (2007).
  Article Google Scholar
• Lee, J. A. & Lupski, J. R. Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron 52, 103–121 (2006).
  Article CAS Google Scholar
• Ensenauer, R. E. et al. Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients. Am. J. Hum. Genet. 73, 1027–1040 (2003).
  Article CAS Google Scholar
• Yobb, T. M. et al. Microduplication and triplication of 22q11.2: a highly variable syndrome. Am. J. Hum. Genet. 76, 865–876 (2005).
  Article CAS Google Scholar
• Paylor, R. et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl Acad. Sci. USA 103, 7729–7734 (2006).
  Article CAS ADS Google Scholar
• Long, J. M. et al. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 7, 247–257 (2006).
  Article Google Scholar
• Yagi, H. et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 362, 1366–1373 (2003).
  Article CAS Google Scholar
• Hiroi, N. et al. A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice. Proc. Natl Acad. Sci. USA 102, 19132–19137 (2005).
  Article CAS ADS Google Scholar
• Paterlini, M. et al. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nature Neurosci. 8, 1586–1594 (2005).
  Article CAS Google Scholar
• Stark, K. L. et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nature Genet. 40, 751–760 (2008). This paper suggests a novel pathophysiological mechanism for the cognitive and psychiatric phenotypes observed in the human 22q11.2 deletion syndrome: abnormal miRNA biogenesis.
  Article CAS Google Scholar
• Lalande, M. & Calciano, M. A. Molecular epigenetics of Angelman syndrome. Cell Mol. Life Sci. 64, 947–960 (2007).
  Article CAS Google Scholar
• Battaglia A. The inv dup(15) or idic(15) syndrome: a clinically recognisable neurogenetic disorder. Brain Dev. 27, 365–369 (2005).
  Article Google Scholar
• Sahoo, T. et al. Prader–Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nature Genet. 40, 719–721 (2008). This paper confirms the cause of PWS — deficiency of non-coding RNA molecules important for normal RNA processing — and suggests a novel role for snoRNAs in cognitive and psychiatric disease.
  Article CAS Google Scholar
• Miura, K. et al. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol. Dis. 9, 149–159 (2002).
  Article CAS Google Scholar
• Gallagher, R. C., Pils, B., Albalwi, M. & Francke, U. Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader–Willi syndrome. Am. J. Hum. Genet. 71, 669–678 (2002).
  Article CAS Google Scholar
• Ding, F. et al. SnoRNA Snord116 (Pwcr1/MBII-85) deletion causes growth deficiency and hyperphagia in mice. PLoS ONE 3, e1709 (2008).
  Article ADS Google Scholar
• Elsea, S. H. & Girirajan, S. Smith–Magenis syndrome. Eur. J. Hum. Genet. 16, 412–421 (2008).
  Article CAS Google Scholar
• Girirajan, S. et al. How much is too much? Phenotypic consequences of Rai1 overexpression in mice. Eur. J. Hum. Genet. 16, 941–954 (2008).
  Article CAS Google Scholar
• Smith, A. C. et al. Interstitial deletion of (17)(p11.2p11.2) in nine patients. Am. J. Med. Genet. 24, 393–414 (1986).
  Article CAS Google Scholar
• Chen, K. S. et al. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. Nature Genet. 17, 154–163 (1997).
  Article CAS Google Scholar
• Slager, R. E., Newton, T. L., Vlangos, C. N., Finucane, B. & Elsea, S. H. Mutations in RAI1 associated with Smith–Magenis syndrome. Nature Genet. 33, 466–468 (2003).
  Article CAS Google Scholar
• Imai, Y. et al. Cloning of a retinoic acid-induced gene, GT1, in the embryonal carcinoma cell line P19: neuron-specific expression in the mouse brain. Brain Res. Mol. Brain Res. 31, 1–9 (1995).
  Article CAS Google Scholar
• Bi, W. et al. Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith–Magenis syndrome. Hum. Genet. 115, 515–524 (2004).
  Article CAS Google Scholar
• Bi, W. et al. Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith–Magenis syndrome. Hum. Mol. Genet. 14, 983–995 (2005).
  Article CAS Google Scholar
• Bi, W. et al. Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes. Hum. Mol. Genet. 16, 1802–1813 (2007).
  Article CAS Google Scholar
• Potocki, L. et al. Molecular mechanism for duplication 17p11.2 — the homologous recombination reciprocal of the Smith–Magenis microdeletion. Nature Genet. 24, 84–87 (2000).
  Article CAS Google Scholar
• Potocki, L. et al. Characterization of Potocki–Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am. J. Hum. Genet. 80, 633–649 (2007).
  Article CAS Google Scholar
• Walz, K., Paylor, R., Yan, J., Bi, W. & Lupski, J. R. Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2). J. Clin. Invest. 116, 3035–3041 (2006).
  Article CAS Google Scholar
• Moretti, P. & Zoghbi, H. Y. MeCP2 dysfunction in Rett syndrome and related disorders. Curr. Opin. Genet. Dev. 16, 276–281 (2006).
  Article Google Scholar
• Chahrour, M. & Zoghbi, H. Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422–437 (2007).
  Article CAS Google Scholar
• Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genet. 23, 185–188 (1999).
  Article CAS Google Scholar
• del Gaudio, D. et al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet. Med. 8, 784–792 (2006).
  Article CAS Google Scholar
• Van Esch, H. et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet. 77, 442–453 (2005).
  Article CAS Google Scholar
• Meins, M. et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J. Med. Genet. 42, e12 (2005).
  Article CAS Google Scholar
• Friez, M. J. et al. Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics 118, e1687–e1695 (2006).
  Article Google Scholar
• Smyk, M. et al. Different-sized duplications of Xq28, including MECP2, in three males with mental retardation, absent or delayed speech, and recurrent infections. Am. J. Med. Genet. B 147B, 799–806 (2008).
  Article CAS Google Scholar
• Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse _Mecp2_-null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genet. 27, 322–326 (2001).
  Article CAS Google Scholar
• Collins, A. L. et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13, 2679–2689 (2004).
  Article CAS Google Scholar
• Samaco, R. C. et al. A partial loss of function allele of methyl-CpG-binding protein predicts a human neurodevelopmental syndrome. Hum. Mol. Genet. 17, 1718–1727 (2008).
  Article CAS Google Scholar
• Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320, 1224–1229 (2008).
  Article CAS ADS Google Scholar
• Yasui, D. H. et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl Acad. Sci. USA 104, 19416–19421 (2007).
  Article CAS ADS Google Scholar
• Chao, H.-T., Zoghbi, H. & Rosenmund, C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58–65 (2007). This paper provides evidence that either loss or gain of MeCP2 alters excitatory synaptic function, leading to overlapping abnormal neurological phenotypes.
  Article CAS Google Scholar
• Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52, 255–269 (2006).
  Article CAS Google Scholar
• Martinowich, K. et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890–893 (2003).
  Article CAS ADS Google Scholar
• McGill, B. E. et al. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA 103, 18267–18272 (2006).
  Article CAS ADS Google Scholar
• Bourgeron, T. The possible interplay of synaptic and clock genes in autism spectrum disorders. Cold Spring Harb. Symp. Quant. Biol. 72, 645–654 (2007).
  Article CAS Google Scholar
• Berg, J. S. et al. Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams–Beuren syndrome region. Genet. Med. 9, 427–441 (2007).
  Article Google Scholar
• Somerville, M. J. et al. Severe expressive-language delay related to duplication of the Williams–Beuren locus. N. Engl. J. Med. 353, 1694–1701 (2005).
  Article CAS Google Scholar
• Torniero, C. et al. Cortical dysplasia of the left temporal lobe might explain severe expressive-language delay in patients with duplication of the Williams–Beuren locus. Eur. J. Hum. Genet. 15, 62–67 (2007).
  Article CAS Google Scholar
• Ewart, A. K. et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nature Genet. 5, 11–16 (1993).
  Article CAS Google Scholar
• Tassabehji, M. Williams–Beuren syndrome: a challenge for genotype–phenotype correlations. Hum. Mol. Genet. 12 (special no. 2), R229–R237 (2003).
  Article CAS Google Scholar
• Zhao, C. et al. Hippocampal and visuospatial learning defects in mice with a deletion of frizzled 9, a gene in the Williams syndrome deletion interval. Development 132, 2917–2927 (2005).
  Article CAS Google Scholar
• Hoogenraad, C. C. et al. Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice. Nature Genet. 32, 116–127 (2002).
• Meng, Y. et al. Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 35, 121–133 (2002).
  Article CAS Google Scholar
• Heredia, L. et al. Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid β-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease. J. Neurosci. 26, 6533–6542 (2006).
  Article CAS Google Scholar
• Lim, M. K. et al. Parkin interacts with LIM kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination. Exp. Cell Res. 313, 2858–2874 (2007).
  Article CAS Google Scholar